calcium 1,3-hydroxypropyl phosphate
Suppliers
Names
[ CAS No. ]:
58409-70-4
        
[ Name ]:
 calcium 1,3-hydroxypropyl phosphate
        
[Synonym ]:
                
                calcium 1,3-hydroxypropyl phosphate
                
                
            
                
                1,3-Dihydroxy-2-propanyl dihydrogen phosphate - calcium (1:1)
                
                
            
                
                1,2,3-Propanetriol, 2-(dihydrogen phosphate), calcium salt (1:1)
                
                
            
                
                glycerophosphate calcium
                
                
            
                
                GLYCEROPHOSPHATE CALCIUM SALT
                
                
            
                
                calcium glycerophosphate,neurosin
                
                
            
                
                Glycerol phosphate calcium salt
                
                
                
                
    
Chemical & Physical Properties
[ Molecular Formula ]:
C3H9CaO6P
            
[ Molecular Weight ]:
212.152
            
[ Exact Mass ]:
211.976273
            
[ PSA ]:
117.03000
            
MSDS
Safety Information
[ Personal Protective Equipment ]:
 dust mask type N95 (US);Eyeshields;Gloves
            
[ Hazard Codes ]:
 Xi
            
[ Risk Phrases ]:
 36/37/38
            
[ Safety Phrases ]:
 26-36
            
[ RIDADR ]: 
NONH for all modes of transport
            
[ HS Code ]:
 2919900090
            
Customs
[ HS Code ]: 2919900090
[ Summary ]: 
2919900090 other phosphoric esters and their salts, including lactophosphates; their halogenated, sulphonated, nitrated or nitrosated derivatives。supervision conditions:AB(certificate of inspection for goods inward,certificate of inspection for goods outward)。VAT:17.0%。tax rebate rate:9.0%。MFN tariff:6.5%。general tariff:30.0%
            
Articles
J. Cell. Biochem. 113(5) , 1776-86, (2012)
Vascular calcification (VC) is frequent prevalence in patients with chronic kidney disease (CKD) and atherosclerosis. Lanthanum carbonate is used as an orally administered phosphate-binding agent to r...
J. Biomed. Mater. Res. A 101(4) , 942-53, (2013)
The purpose of this study was to generate tissue-engineered bone using human periosteal-derived osteoblasts (PO) and polydioxanone/pluronic F127 (PDO/pluronic F127) scaffold with preseeded human perio...
Exp. Cell Res. 322(2) , 302-12, (2014)
Vascular calcification is highly prevalent in patients with chronic kidney disease (CKD) and contributes to increased risk of cardiovascular disease and mortality. Accumulated evidences suggested that...